BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25895652)

  • 1. Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.
    Butt AQ; McArdle A; Gibson DS; FitzGerald O; Pennington SR
    Curr Rheumatol Rep; 2015 May; 17(5):35. PubMed ID: 25895652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.
    McArdle A; Pennington S; FitzGerald O
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):271-294. PubMed ID: 28748366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and confirmation of a protein biomarker panel with potential to predict response to biological therapy in psoriatic arthritis.
    Ademowo OS; Hernandez B; Collins E; Rooney C; Fearon U; van Kuijk AW; Tak PP; Gerlag DM; FitzGerald O; Pennington SR
    Ann Rheum Dis; 2016 Jan; 75(1):234-41. PubMed ID: 25187158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early biomarkers of joint damage in rheumatoid and psoriatic arthritis.
    Mc Ardle A; Flatley B; Pennington SR; FitzGerald O
    Arthritis Res Ther; 2015 Jun; 17(1):141. PubMed ID: 26028339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriatic arthritis: a diagnostic challenge?
    Buder K; Wozel G
    G Ital Dermatol Venereol; 2010 Jun; 145(3):407-14. PubMed ID: 20461048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of biomarkers as a tool for novel psoriatic disease drug discovery.
    Aggarwal D; Arumalla N; Jethwa H; Abraham S
    Expert Opin Drug Discov; 2018 Sep; 13(9):875-887. PubMed ID: 30124339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriatic rheumatism. Inflammatory arthropathy.
    Macovei L; Brujbu I
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):45-51. PubMed ID: 24741774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Treatment Concepts in Psoriatic Arthritis.
    Boyd T; Kavanaugh A
    Rheum Dis Clin North Am; 2015 Nov; 41(4):739-54. PubMed ID: 26476230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.
    Collins ES; Butt AQ; Gibson DS; Dunn MJ; Fearon U; van Kuijk AW; Gerlag DM; Pontifex E; Veale DJ; Tak PP; FitzGerald O; Pennington SR
    Proteomics Clin Appl; 2016 Jun; 10(6):645-62. PubMed ID: 26108918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early psoriatic arthritis.
    Gladman DD
    Rheum Dis Clin North Am; 2012 May; 38(2):373-86. PubMed ID: 22819090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
    Coates LC; FitzGerald O; Helliwell PS; Paul C
    Semin Arthritis Rheum; 2016 Dec; 46(3):291-304. PubMed ID: 27388027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts and unmet needs in psoriatic arthritis.
    Mahmood F; Coates LC; Helliwell PS
    Clin Rheumatol; 2018 Feb; 37(2):297-305. PubMed ID: 29134513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
    Gottlieb A; Korman NJ; Gordon KB; Feldman SR; Lebwohl M; Koo JY; Van Voorhees AS; Elmets CA; Leonardi CL; Beutner KR; Bhushan R; Menter A
    J Am Acad Dermatol; 2008 May; 58(5):851-64. PubMed ID: 18423261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers and prognostic stratification in psoriatic arthritis.
    Bogliolo L; Crepaldi G; Caporali R
    Reumatismo; 2012 Jun; 64(2):88-98. PubMed ID: 22690385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidly progressive destructive arthritis in psoriatic arthritis sine psoriasis: do bone resorption marker levels predict outcome of bone destruction in psoriatic arthritis?
    Taniguchi Y; Kumon Y; Shimamura Y; Kobayashi S; Terada Y
    Mod Rheumatol; 2011 Feb; 21(1):106-8. PubMed ID: 20625790
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of psoriatic arthritis - epidemiology, clinical features, pathophysiology and novel treatment targets.
    Kerschbaumer A; Fenzl KH; Erlacher L; Aletaha D
    Wien Klin Wochenschr; 2016 Nov; 128(21-22):791-795. PubMed ID: 27822746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for rheumatoid and psoriatic arthritis.
    Verheul MK; Fearon U; Trouw LA; Veale DJ
    Clin Immunol; 2015 Nov; 161(1):2-10. PubMed ID: 25934385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Integrative Approach to Biomarker Development in Psoriatic Arthritis.
    Ritchlin CT
    J Rheumatol Suppl; 2015 Nov; 93():43-7. PubMed ID: 26523056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Approaches in Tumor Necrosis Factor Antagonism for the Treatment of Psoriatic Arthritis: Certolizumab Pegol.
    Cauli A; Piga M; Lubrano E; Marchesoni A; Floris A; Mathieu A
    J Rheumatol Suppl; 2015 Nov; 93():70-2. PubMed ID: 26523062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in psoriatic arthritis: recent progress.
    Chandran V; Scher JU
    Curr Rheumatol Rep; 2014 Nov; 16(11):453. PubMed ID: 25218735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.